Ivermectin for Covid-19
The site is identified as “Ivermectin for Covid-19” and carries the description “c19early: COVID-19 treatment analysis.” Its homepage states that the publisher is the organization c19early, with no parent organization stated.
- Credibility
- Unrated
- Lean
- Unrated
- Articles read
- 0
In today’s Brief
Saturday 7 NovemberNot in today’s Brief.
Ivermectin for Covid-19
The site is identified as “Ivermectin for Covid-19” and carries the description “c19early: COVID-19 treatment analysis.” Its homepage states that the publisher is the organization c19early, with no parent organization stated.
- Credibility
- Unrated
- Lean
- Unrated
- Articles read
- 0
In today’s Brief
Saturday 7 NovemberNot in today’s Brief.
Profile
- Type
- Other
- Ownership
- The homepage states that c19early is the publisher of ivmmeta.com; no parent organization is stated.
- Language
- English
ProfileAI-generated summaryWritten under a strict no-guessing rule. Facts the model isn’t sure of are left out.Verify independently before citing.Fetched 8 November, 00:53 UTCRatingsAllSides and Media Bias/Fact CheckLean and credibility come from public ratings (AllSides, MBFC).Unknown outlets stay unrated.Curated v1 mapping